/VSBC
VSBC Stock - VitaSpring Biomedical Co. Ltd.
Healthcare|BiotechnologyOTC
$1.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VSBC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.99 – $1.01
TARGET (TP)$1.15
STOP LOSS$0.92
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-2.21
52W High$16.00
52W Low$0.10
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | $5.61M | $248,200 | $15,140 | $17,180 |
| Gross Profit | $-219,335 | $2.07M | $112,200 | $1,695 | $13,267 |
| Gross Margin | N/A | 36.8% | 45.2% | 11.2% | 77.2% |
| Operating Income | $-4,177,836 | $1.48M | $-425,382 | $-19,486 | $-21,330 |
| Net Income | $-4,164,396 | $1.26M | $-425,382 | $6,919 | $-22,396 |
| Net Margin | N/A | 22.5% | -171.4% | 45.7% | -130.4% |
| EPS | $-0.02 | $0.01 | $-0.00 | $0.00 | $-0.00 |
Company Overview
VitaSpring Biomedical Co. Ltd. focuses on the development of drugs of cell medicine. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is headquartered in Irvine, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VSBCBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2022
EPS Surprise History
Q1 21
No data
Q2 21
No data
Q3 21
No data
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2022 | Dec 21, 2022 | — | $-0.00 | — | — |
Q3 2022 | Jul 31, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 30, 2022 | — | $0.00 | — | — |
Q1 2022 | Jan 31, 2022 | — | $0.00 | — | — |
Q4 2021 | Oct 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Jul 31, 2021 | — | $0.00 | — | — |
Q2 2021 | Apr 30, 2021 | — | $0.01 | — | — |
Q1 2021 | Jan 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Oct 31, 2020 | — | $-0.00 | — | — |
Q3 2020 | Jul 31, 2020 | — | $-0.00 | — | — |
Q2 2020 | Apr 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Jan 31, 2020 | — | $0.00 | — | — |
Q4 2019 | Oct 31, 2019 | — | $-0.00 | — | — |
Q2 2019 | Apr 30, 2019 | — | $-0.00 | — | — |
Q1 2019 | Jan 31, 2019 | — | $-0.00 | — | — |
Q4 2018 | Oct 31, 2018 | — | $-0.00 | — | — |
Q3 2018 | Jul 31, 2018 | — | $-0.00 | — | — |
Q2 2018 | Apr 30, 2018 | — | $0.00 | — | — |
Q1 2018 | Jan 31, 2018 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about VSBC
What is VSBC's current stock price?
VitaSpring Biomedical Co. Ltd. (VSBC) is currently trading at $1.00 per share. The stock has moved +0.00% today.
What is the analyst price target for VSBC?
No analyst price targets are currently available for this stock.
What sector is VitaSpring Biomedical Co. Ltd. in?
VitaSpring Biomedical Co. Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is VSBC's market cap?
VitaSpring Biomedical Co. Ltd. has a market capitalization of $0.21 billion, making it a small-cap company.
Does VSBC pay dividends?
No, VitaSpring Biomedical Co. Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAURX
Nuo Therapeutics, Inc.
$2.15
Mkt Cap: $0.1B
GGBXF
Green Growth Brands Inc.
$0.00
Mkt Cap: $0.0B
IUGNF
Imugene Limited
$0.22
Mkt Cap: $0.1B
KNTPF
Kintor Pharmaceutical Limited
$0.22
Mkt Cap: $0.1B
MSCLF
Satellos Bioscience Inc.
$0.48
Mkt Cap: $0.1B
PBIGF
Paradigm Biopharmaceuticals Limited
$0.23
Mkt Cap: $0.1B
POLBF
Poolbeg Pharma PLC
$0.04
Mkt Cap: $0.0B
SHIEF
Shield Therapeutics plc
$0.09
Mkt Cap: $0.1B
SPHRY
Starpharma Holdings Limited
$2.20
Mkt Cap: $0.1B
TOKIF
Optima Medical Innovations Corp.
$0.01
Mkt Cap: $0.1B
Explore stocks similar to VSBC for comparison